Turn Therapeutics CEO to present at Jefferies Global Healthcare Conference June 4
Turn Therapeutics announced its CEO Bradley Burnam will present at the Jefferies Global Healthcare Conference on June 4, 2026. The company's lead candidate GX-03 is in Phase 2 trials for atopic dermatitis with topline results expected mid-2026.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day